Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M435Revenue (TTM) $M31.0Net Margin (%)-150.3Altman Z-Score-3.7
Enterprise Value $M390EPS (TTM) $-0.6Operating Margin %-130.0Piotroski F-Score2
P/E(ttm)--Beneish M-Score-2.5Pre-tax Margin (%)-150.3Higher ROA y-yN
Price/Book10.410-y EBITDA Growth Rate %-5.7Quick Ratio1.9Cash flow > EarningsY
Price/Sales12.95-y EBITDA Growth Rate %-9.3Current Ratio1.9Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-46.9Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-272.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M80.4ROIC % (ttm)-676.4Gross Margin Increase y-yN

Gurus Latest Trades with BCRX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

BCRX is held by these investors:



BCRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
STAAB THOMAS R IISenior Vice President and CFO 2017-03-20Sell3,250$9.2-41.2view
STAAB THOMAS R IISenior Vice President and CFO 2017-03-10Sell3,250$9.06-40.29view
STAAB THOMAS R IISenior Vice President and CFO 2017-03-08Sell6,500$8.43-35.82view
STAAB THOMAS R IISenior Vice President and CFO 2017-03-06Sell3,250$7.9-31.52view
STAAB THOMAS R IISenior Vice President and CFO 2016-12-19Sell3,250$7.45-27.38view
Barnes Alane PVP, General Counsel & Corp Sec 2016-09-14Sell8,357$4.2726.7view
Babu Yarlagadda SSenior VP - Drug Discovery 2016-08-25Sell30,000$4.0633.25view
BAKER BROS. ADVISORS LP10% Owner 2016-08-16Sell4,046,590$58.2view
STAAB THOMAS R IISenior Vice President and CFO 2016-08-12Sell5,864$5.184.44view
STAAB THOMAS R IISenior Vice President and CFO 2016-08-09Sell14,577$4.4322.12view

Press Releases about BCRX :

Quarterly/Annual Reports about BCRX:

News about BCRX:

Articles On GuruFocus.com
7 of the Worst-Performing Stocks in Gurus' Portfolios Jul 07 2017 
BioCryst to Present at the JMP Securities 2017 Life Sciences Conference Jun 13 2017 
BioCryst Announces RAPIVAB® Pediatric sNDA Acceptance Jun 05 2017 
BioCryst to Present at the Jefferies 2017 Global Healthcare Conference May 31 2017 
Robert A. Ingram Named Chairman of BioCryst Pharmaceuticals, Inc. May 30 2017 
BioCryst Reports Additional Positive Results From the Second Interim Analysis of Its APeX-1 Trial May 25 2017 
BioCryst to Present at the Bank of America Merrill Lynch 2017 Health Care Conference May 09 2017 
BioCryst Reports First Quarter 2017 Financial Results May 04 2017 
BioCryst to Announce First Quarter 2017 Financial Results May 4 Apr 24 2017 
BioCryst Expands Development of BCX7353 to Explore Treatment of Acute HAE Attacks Apr 12 2017 

More From Other Websites
BioCryst Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : BCRX-US :... Jul 18 2017
ETFs with exposure to BioCryst Pharmaceuticals, Inc. : July 13, 2017 Jul 13 2017
Today's Research Reports on Stocks to Watch: BioCryst Pharmaceuticals and Exact Sciences Jul 07 2017
BioCryst Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : BCRX-US :... Jul 04 2017
BioCryst Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : BCRX-US :... Jun 21 2017
ETFs with exposure to BioCryst Pharmaceuticals, Inc. : June 16, 2017 Jun 16 2017
Biotech Industry Showing Signs of a Revival in 2017: Today's Research on BioCryst Pharmaceuticals... Jun 15 2017
BioCryst Pharmaceuticals, Inc. :BCRX-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017 Jun 14 2017
BioCryst to Present at the JMP Securities 2017 Life Sciences Conference Jun 13 2017
Down 24.6%, is BioCryst Pharmaceuticals Stock Now a Buy? Jun 06 2017
Flu therapy from RTP's BioCryst could be available for kids next season Jun 06 2017
BioCryst Announces RAPIVAB® Pediatric sNDA Acceptance Jun 05 2017
BioCryst to Present at the Jefferies 2017 Global Healthcare Conference May 31 2017
Robert A. Ingram Named Chairman of BioCryst Pharmaceuticals, Inc. May 30 2017
Why Zoe's Kitchen, Beazer Homes, and BioCryst Pharmaceuticals Slumped Today May 26 2017
BioCryst and Aerie Pharmaceuticals' Shares Swell on Positive Study Results May 26 2017
Why BioCryst Pharmaceuticals Stock Caught Fire Today May 25 2017
Stocks rise for Aerie, BioCryst following positive trial results May 25 2017
Biotech Movers: Positive Phase Three Results For Roclatan Send Aerie Shares Soaring May 25 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}